By delivering this special New Year Edition of the OncoWuXi Newsletter, we would like to extend our sincere appreciation for your continued interest in OncoWuXi database, and wish you a happy, healthy and prosperous New Year! This Special Edition will bring you our full-year database overview on target identification and validation, biomarker, targeted oncology, immuno-oncology, and immunology platforms.

It has been our pleasure to collaborate with you throughout the year and with a deep gratitude for your continued trust and support, we look forward to serving you again in 2021!

  • CRISPR/Cas9 library-based in vitro & in vivo screening
  • 246 CDX models
  • 28 Orthotopic models
  • 1300+ PDX models
  • 13 CDX models in rat
  • 50+ Drug resistant models
  • 26 Autoimmune disease models
  • GEAM & AAV packaging

  • 61 Syngeneic models
  • 50+ Humanized models
  • 20+ Immune assays
  • Multiplex pathology analysis
  • NanoString & scRNAseq
  • CAP Pathology & FACS lab
  • 100+ Clinical biomarkers
  • Rare genetic disease models